ASCN.SW stock trades at CHF4.85 in pre-market on the SIX as investors position ahead of Ascom Holding AG’s earnings due 09 Mar 2026. The main question is whether revenue and margin signs will justify the current premium valuation — the shares sit at a PE of 60.56 with EPS of CHF0.08. Volume is light at 64,603 shares versus an average 116,231, so we expect sharper moves when the report lands. This earnings spotlight breaks down valuation, cash flow metrics, technicals and Meyka AI’s near-term forecast to help frame the trade.

Earnings catalyst: ASCN.SW stock and the 09 Mar 2026 report

Ascom’s earnings announcement on 09 Mar 2026 is the immediate catalyst for ASCN.SW stock; guidance or surprises on recurring software and service contracts will matter most. Management commentary on hospital digitization, Unite platform adoption and service margins will likely drive the headline numbers. Analysts and investors should watch revenue recognition for Digistat and teleCARE and any update to long-term service agreements.

Price, liquidity and valuation snapshot for ASCN.SW stock

The share price is CHF4.85 with a day range CHF4.75–4.97, year high CHF5.49 and year low CHF2.82. Market cap stands at CHF174026886.00 and shares outstanding are 35,918,862.00. Trailing PE is 60.56, EPS CHF0.08, price/50-day average CHF4.61, and price/200-day average CHF3.99. Average volume is 116,231.00 so today’s 64,603.00 shows lighter trading ahead of results, raising the risk of larger intraday moves on news.

Fundamentals and cash flow: ASCN.SW stock financials

Ascom shows positive free cash flow yield of 15.80% and operating cash flow per share CHF0.82, signalling healthy cash conversion given the size of the company. Gross margin is 46.84% and net margin is 1.05%, highlighting margin pressure and a need for better operating leverage. Book value per share is CHF1.97 and tangible book CHF1.12, with no net debt and an enterprise value of CHF144526886.00, which supports a conservative resilience case despite slow EPS growth.

Technicals and trading picture for ASCN.SW stock

Momentum is mixed: RSI 48.63 and ADX 26.60 suggesting a trend is forming but not strong; Bollinger middle band sits at CHF5.12 with a lower band CHF4.88. Short-term average price is above the 50-day mean CHF4.61, while MACD histogram is slightly negative. Liquidity is moderate and relative volume is 0.56, so expect earnings to amplify moves. Watch support near CHF4.75 and resistance near CHF5.12–5.36.

Meyka AI grade, models and ASCN.SW stock forecast

Meyka AI rates ASCN.SW with a score of 72.88 out of 100 — Grade B+, Suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a short-term quarterly target of CHF6.32 and a one-year model value of CHF4.16. The model highlights a potential near-term upside if margins stabilise, while the one-year scenario assumes normalisation and modest revenue growth. Forecasts are model-based projections and not guarantees.

Risks and upside: ASCN.SW stock opportunities and hazards

Upside drivers include stronger recurring revenue from Unite and Digistat, higher service margins, and cross-selling of mobile workflow devices; a quarterly forecast at CHF6.32 implies meaningful upside if execution improves. Key risks are slow hospital spend, margin compression from hardware sales, and the high PE of 60.56 which leaves little room for earnings misses. Regulatory or procurement delays in key markets would materially affect near-term revenue.

Final Thoughts

Key takeaways for ASCN.SW stock: the shares trade at CHF4.85 pre-market on SIX with earnings due 09 Mar 2026, making this a short-term event trade. Valuation is elevated with a trailing PE of 60.56 and EPS CHF0.08, but the company reports healthy cash flow metrics and a net cash position that support operational flexibility. Meyka AI’s forecast model projects a quarterly target of CHF6.32 (implied upside 30.31% vs current price) and a one-year model value of CHF4.16 (implied downside -14.34%). A three-year projection of CHF5.04 implies modest upside of 3.87%. Investors should treat the earnings release as a binary event: positive guidance or margin beats could validate the higher target, while any revenue or margin softness could quicken a re-rating. Forecasts are model-based projections and not guarantees. For background on strategy and recent corporate updates, see Ascom’s investor pages and company site and check the Meyka stock page for ASCN.SW for live signals and real-time model updates. Meyka AI is an AI-powered market analysis platform that provides event-driven forecasts and sector context to help frame these scenarios.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.